RORγ Inhibitors for the Treatment of Autoimmune Disease


Orca Pharmaceuticals is a company based in Oxford UK developing oral drugs for the treatment of chronic inflammatory disease. Based on the pioneering work of Professor Dan Littman, we have a medicinal chemistry programme producing orally available inhibitors of RORγ, a nuclear hormone receptor found in a class of white blood cell involved autoimmune disease. 



Find out about our novel treatments for autoimmune disease 

Learn More →


Get to know the drug development team

Find Out More →